News
Qatar is a cultural beacon for the entire MENASA region. It is thrilling to be given this opportunity to design Qatar's Pavilion on the historic grounds of the Giardini of La Biennale di Venezia." ...
Doha, Qatar: Qatar Museums has announced the return of Design Doha Biennale, set to take place from April 16 to June 30, 2026. Following a landmark debut in 2024, the second edition promises to be ...
Meet the trailblazing women in Qatar’s creative industries, from art and design, to fashion and film
Qatar 365 celebrates Women’s History Month ... Laila Humairah met artists with a unique take on art and design. Aadel Haleem spoke with Fatma Al-Remaihi, CEO of the Doha Film Institute.
Here are three reasons why you should be careful with REGN and a stock we'd rather own. Founded by scientists who wanted to build a company where science could thrive, Regeneron Pharmaceuticals ...
In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other best biotech stocks. Although biotech stocks had a “challenging” year ...
Dailymotion on MSN26d
Meet the trailblazing women in Qatar’s creative industries, from art and design, to fashion and filmQatar 365 celebrates Women’s History Month, spotlighting female creatives in Qatar that are pushing the boundaries in visual arts, cinematography, and fashion.
Images of the selected design have not yet been released. The announcement of Qatar's permanent pavilion follows the signing of a Protocol of Cooperation between Qatar Museums and the ...
Qatar has selected Lina Ghotmeh as the architect to create the permanent Qatar Pavilion for the Venice Biennale. To be ...
In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against ... for precision oncology and protein design. The RNA therapeutics sector ...
In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other blue chip stocks to invest in at 52-week lows. For the first time since ...
Regeneron Pharmaceuticals (NASDAQ:REGN) is a large cap pharmaceutical company that is best known for its VEGF inhibitor, Eylea, for the treatment of various eye disorders like wet AMD. Within the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results